NCT03784482View on ClinicalTrials.gov

Multiple Drug Hypersensitivity Syndrome

CompletedOBSERVATIONAL
Enrollment

50

Participants

Timeline

Start Date

December 20, 2018

Primary Completion Date

June 30, 2019

Study Completion Date

July 31, 2019

Conditions
Drug Allergy
Trial Locations (1)

34295

University hospital of Montpellier, Montpellier

All Listed Sponsors
lead

University Hospital, Montpellier

OTHER

NCT03784482 - Multiple Drug Hypersensitivity Syndrome | Biotech Hunter | Biotech Hunter